PET DIABETES CARE DEVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)
The global pet diabetes care devices market is estimated to be valued at USD 2.42 Billion in 2024 and is expected to reach USD 3.91 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 7.1% from 2024 to 2031. The rising prevalence of diabetes in pets owing to obesity and lack of physical activity as well as increasing pet ownership globally is expected to drive the demand for pet diabetes care devices over the forecast period.
Discover market dynamics shaping the industry: Request sample copy
Market Driver - Increasing awareness about pet health and wellness
In recent years, people have become much more aware about the health and well-being of their pets. Just like humans, pets can suffer from various diseases if proper care is not taken. Owners have started to pay closer attention to their pet's diet, exercise routines, and overall lifestyle. They want to ensure their furry companions live a long and healthy life. This increasing focus on pet health has led more owners to regularly take their dogs and cats for checkups and medical examinations. Veterinarians play a big role in educating pet parents about common ailments and how to monitor for signs of illnesses. As people continue to treat their pets as valued family members, preventive healthcare is gaining prominence. Diabetes is one such condition that veterinarians have been helping owners identify early. They explain how just like in humans, pets too can become diabetic if their pancreas stops producing enough insulin or if cells stop responding to the insulin produced. Left unmanaged, diabetes can lead to severe problems affecting organs and overall quality of life in pets. Therefore, veterinary professionals advise routine tests for diabetics symptoms so the disease can be controlled through diet, exercise and medication. Some may even need insulin injections or advanced diabetes care devices. With growing awareness about diabetes in general, many owners have become familiar with its symptoms and risks for pets. They no longer consider it just a human disease but also diligently check their dog or cat's urine and watch for excessive thirst or hunger.
Get actionable strategies to beat competition: Request sample copy
Rising incidence of diabetes
Along with awareness, the actual incidence of diabetes is rising rapidly in pets over the past decade. Certain breeds of dogs such as Poodles, Dachshunds and Terriers have a higher genetic risk for the disease. Even cats are quite prone to diabetes, especially older and obese felines. The core reasons attributed to increased diabetes cases are unhealthy pet diets, lack of exercise, and growing rates of obesity. Much like humans, pets too are victims of consuming low-quality commercial foods filled with carbohydrates, salts, and fats. Coupled with a sedentary lifestyle lacking physical activity, this has contributed substantially to weight gain issues across dog and cat populations. Excess weight is a major diabetes risk factor and the sizes of pet animals have ballooned over the years due to unhealthy dietary habits. While genetic predisposition cannot be altered, modifiable lifestyle factors associated with diabetes are well within control. With more owners now conscious about healthy pet nourishment and lifestyle maintenance, preventive approaches can help stem the diabetes tide. Still, the reality remains that more pets will require careful glucose management and advanced treatment solutions in the foreseen future. This growing diabetes patient pool indicates a marked need for innovative monitoring devices and therapies. Early diagnosis alongside consistent care ensures pets have the best outcomes and quality of lives despite the challenging disease. It also saves owners from the substantial costs involved with neglecting a diabetic pet's condition.
Key Takeaways from Analyst:
The global pet diabetes care devices market is poised to witness steady growth over the next decade. Rising pet healthcare expenditure along with increasing pet ownership is a major factor driving demand for pet diabetes care devices. Moreover, growing awareness among pet owners about diabetes management and care is propelling the market growth.
North America currently dominates the market aided by high disposable income of pet owners and advanced pet healthcare infrastructure in the region. However, Asia Pacific is expected to be the fastest growing market attributed to burgeoning pet population, rising awareness, and improving veterinary facilities. Non-invasive monitoring devices, such as blood glucose meters, are highly popular owing to their low cost and ease-of-use. However, insulin delivery devices are also gaining more traction among pet owners and vets alike for streamlining diabetes management. That said, high product costs remain a key restraint to the market's growth potential globally.
The market provides ample opportunities for players to invest in R&D and the development of cost-effective, user-friendly products. Gaining regulatory approvals and penetrating emerging markets also present lucrative expansion pathways. Manufacturers could focus on marketing initiatives to raise awareness about the importance of glucose monitoring and consistent medication. Collaborating with veterinarians and veterinary clinics could also boost sales revenues in the long-run.
Market Challenge - High cost of pet diabetes care devices
One of the major challenges faced by the global pet diabetes care devices market is the high cost of these medical devices. The glucose monitoring systems and insulin delivery devices required for managing diabetes in pets are often very expensive. This poses a significant financial burden on pet owners and prevents many from regularly monitoring their pet's blood glucose levels or administering insulin as recommended. The costly nature of pet diabetes products like insulin pens, syringes, and test strips means that only affluent pet owners can routinely afford the treatment costs. The high prices are largely due to the smaller production volumes and additional research costs involved to tailor existing human diabetes devices for veterinary use. This market challenge restricts the accessibility of effective diabetes management solutions to a limited demographic and hampers overall market growth. For the market to thrive, bringing down the prices of essential pet diabetes care devices through innovations in manufacturing processes and more competition is crucially needed.
Market opportunities: Development of affordable point-of-care diabetic care solutions for pets
One of the major opportunities present in the global pet diabetes care devices market is the development of more affordable point-of-care solutions. Currently, many pet owners find it difficult to regularly monitor their pets' blood glucose levels or administer insulin treatment due to the significant recurring costs involved. This gap in the market has opened up scope for companies to develop low-cost yet efficacious point-of-care devices especially tailored for convenient diabetes care of pets at home. Such affordable solutions could include portable blood glucose meters with discounted test strips, simplified insulin pens or patches, and miniaturized insulin pumps for easier measurement and administration of medication by pet owners. Catering to price-sensitive customers through value-based product offerings will help gain greater penetration in emerging markets and appeal to a wider customer segment globally. It can be a lucrative strategy for manufacturers to tap into this largely untapped opportunity of providing budget-friendly point-of-care options.
Discover high revenue pocket segments and roadmap to it: Request sample copy
By Animal Type - Dog ownership drives the demand for canine diabetes care
In terms of animal type, dogs is expected to contribute the highest share of the market, accounting for 59.1% in 2024 owing to their popularity as companion pets globally. Many families consider dogs an essential part of the household and are willing to invest heavily in their health and wellbeing. As dogs have longer lifespans now due to advancements in veterinary care, they are also susceptible to age-related illnesses like diabetes just as humans are. This "pet parent" attitude leads to higher spending on diabetes management products for dogs compared to other pet types. Additionally, certain dog breeds have a genetic predisposition to diabetes which contributes to the growing caseload. Increased public awareness about pet health through social media also drives more proactive diabetes screening and treatment seeking for symptomatic dogs. Overall, the deep emotional bonds and investment people have in their dogs is a primary factor supporting the diabetes care devices market for canines.
By Solutions - Treatment modalities drive the demand for solutions
In terms of solutions, treatment is expected to contribute the highest share of the market with 55% share in 2024 driven by the need for effective glycemic control in diabetic pets. For pets diagnosed with diabetes, lifelong treatment is required through a combination of insulin therapy, glucose monitoring, and other supporting therapies. Insulin injections administered either by the owner or a veterinarian remain the standard of care for controlling blood sugar levels in both cats and dogs. This steady demand for insulin therapy consistently drives the insulin delivery devices and syringes segment of the market. The important role played by glucose monitoring devices is also rising as more pet owners have become accustomed to routinely checking their pet's blood glucose levels using test strips. Given that uncontrolled diabetes can lead to severe health issues in pets, these monitoring tools aid early intervention. Adjunct treatments like dietary adjustments and supplements also see uptake based on veterinary recommendations to manage diabetes complications long-term. With no permanent cure available, ongoing treatment forms the backbone of diabetes solutions sought for affected pets.
By End User - Veterinary clinics anchor customer base
In terms of end user, veterinary clinics is expected to contribute the highest share of the market with 40% share in 2024 owing to their prominent role in pet diabetes diagnosis and management. As the frontline healthcare providers for pets, veterinary clinics are typically the first point of contact when an owner notices symptoms of diabetes in their pet. Clinics perform the required diagnostic tests to formally establish hyperglycemia and classify the type and severity of diabetes. Post-diagnosis, clinics assume responsibility for educating owners about treatment protocols, demonstrating insulin administration techniques, dispensing insulin and device prescriptions, monitoring response to medications, and adjusting therapies as needed. They also stock a variety of diabetes products and consumables on their premises for fill and refill orders. Clinics thus act as trusted consultants to owners navigating their pet's diabetes journey. While clinics refer some routine care tasks to owners for home management, they remain the primary care providers overseeing the long-term medical supervision pets need. This established clinical relationship drives the majority of demand for diabetes care devices within the channel of veterinary clinics.
To learn more about this report, Request sample copy
North America has established itself as the dominant region in the global pet diabetes care devices market. It is expected hold a market share of 40.3% in 2024. This can be attributed to several factors. The U.S. has the highest pet ownership rate in the world, with over 60% of American households owning a pet. With rising pet obesity rates, diabetes in companion animals is also on the rise. This has boosted the demand for blood glucose monitoring equipment and insulin delivery devices among pet owners in the region. Additionally, North America is home to some of the largest pet pharmaceutical companies that are continuously investing in R&D for novel diabetes care solutions. Being an early adopter of new medical technologies, veterinary clinics and hospitals in the U.S. and Canada are well-equipped with the latest pet diabetes management devices.
Asia Pacific has emerged as the fastest growing regional market for pet diabetes care devices. Countries like China, India, and Japan have witnessed exponential growth in pet care expenditures over the past decade due to rapid urbanization, higher disposable incomes, and shifting cultural preferences. This has led to an increased awareness about pet health issues like diabetes. However, diabetes management previously involved sourcing insulin and vet prescriptions from overseas which drove up costs. But increased local manufacturing of companion animal healthcare products has made pet diabetes care therapy accessible and affordable in Asia Pacific. This has improved diagnosis and treatment rates, significantly boosting demand. Further foreign investments and collaborations between multinational companies and regional animal health startups are also spurring innovations suited to the preferences of Asian pet owners.
Pet Diabetes Care Devices Market Report Coverage
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 2.42 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 7.1% | 2031 Value Projection: | US$ 3.91 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Abbot Laboratories, Inc, Virbac, Medtronic plc, Johnson & Johnson Services, Inc, Roche Diagnostics, Bio-Rad Laboratories, Inc, Novo Nordisk A/S, Zoetis Inc, Terumo Corporation, Boehringer Ingelheim International GmbH, IDEXX Laboratories, Johnson & Johnson Services, Inc, Terumo Corporation, Eli Lilly and Company, Vetoquinol S.A., and i-SENS, Inc. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
*Definition: The global pet diabetes care devices market covers the sale of devices that help manage diabetes in pets such as dogs, cats, and others. This includes insulin delivery devices like insulin pens, syringes, pumps; blood/urine glucose monitoring kits containing lancets, test strips, meters; and other devices such as glucose gel or pastes for external application. The rising prevalence of diabetes in pets, growing pet ownership, increasing pet healthcare expenditure, and technological advancements in pet diabetes care devices are some of the key factors driving the growth of the global pet diabetes care devices.
Share
About Author
Manisha Vibhute is a consultant with over 5 years of experience in market research and consulting. With a strong understanding of market dynamics, Manisha assists clients in developing effective market access strategies. She helps medical device companies navigate pricing, reimbursement, and regulatory pathways to ensure successful product launches.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Credibility and Certifications
860519526
9001:2015
27001:2022
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowSelect a License Type
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 